Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study

作者：Jiehai Yu, Bin-Yi Xiao, Dan-Dan Li, Wu Jiang, Ya Ding, Xiao-Jun Wu, Rong-Xin Zhang, Jun-Zhong Lin, Wei Wang, Kai Han, Ling-Heng Kong, Xin-Ke Zhang, Bi-Yun Chen, Wei-Jian Mei, Zhi-Zhong Pan, Jing-Hua Tang, Xiao-Shi Zhang, Pei-Rong Ding · 发表于：The Lancet Oncology · 年份：2024 · DOI：10.1016/s1470-2045(24)00203-1 · 被引用次数：50 · 研究领域：Genetic factors in colorectal cancer、Colorectal Cancer Surgical Treatments、Cancer Immunotherapy and Biomarkers